CEL-SCI (CVM) Reports Second Quarter 2013 Financial Results
5/13/2013 7:13:13 AM
More...
|
CEL-SCI (CVM) Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model
5/6/2013 10:10:21 AM
More...
|
CEL-SCI (CVM) Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model
5/6/2013 6:51:40 AM
More...
|
CEL-SCI (CVM) to Present at the American Association of Immunologists 100th Annual Meeting on Saturday May 4th
5/3/2013 7:59:34 AM
More...
|
CEL-SCI (CVM) Hires Two CROs; Multikine Phase III Trial Being Expanded
4/24/2013 9:35:58 AM
More...
|
CEL-SCI (CVM) Announces Initiation of New Sites for Multikine Phase III Clinical Study for Head and Neck Cancer in Taiwan
2/25/2013 11:54:56 AM
More...
|
CEL-SCI (CVM) Reports First Quarter 2013 Financial Results
2/11/2013 6:20:47 AM
More...
|
CEL-SCI (CVM) to Present at 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2013 6:29:37 AM
More...
|
CEL-SCI (CVM) and Northeast Ohio Medical University Develop Novel Cancer Vaccine That Prevents and Treats Breast Cancer
1/31/2013 10:24:11 AM
More...
|
CEL-SCI (CVM) Corporation Announces Fiscal 2012 Financial Results
12/17/2012 6:22:50 AM
More...
|
|